Harry Wilders
banner
harrywilders.bsky.social
Harry Wilders
@harrywilders.bsky.social
GSK/Francis Crick Institute Industrial Post-Doctoral Researcher exploring chemoproteomics approaches to covalent drug discovery
Pinned
I am happy to share that our recent work has been published in Angewandte Chemie.

We demonstrate how ‘direct-to-biology’ screening can accelerate optimisation campaigns, yielding potent covalent and non-covalent inhibitors from reactive fragment hits.

onlinelibrary.wiley.com/doi/full/10....
Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening
Direct-to-biology workflows promise to accelerate hit optimisation for drug discovery. Here, we describe a direct-to-biology method for the efficient synthesis and screening of cysteine-reactive frag...
onlinelibrary.wiley.com
Reposted by Harry Wilders
Check out our new paper in @commschem.bsky.social, where we identified a novel enantioselective fragment for the deubiquitinating enzyme, OTUD7B. An absolute pleasure to co-lead this project with Aini Vuorinen and @cassandrakennedy.bsky.social!

www.nature.com/articles/s42...
January 15, 2025 at 2:44 PM
Excited to see this out in Nature Communications. A great platform to profile reactive fragments against the human proteome (and beyond), quickly and accurately.

#ChemBio #Chemsky
January 11, 2025 at 8:36 PM
Reposted by Harry Wilders
Interested in a PhD combining high-throughput synthesis, structural and cell biology to understand kinases? Deadline to apply for a project with Richard Bayliss, Helen Matthews and me: January 6th! www.findaphd.com/phds/project...
Probing covalent mechanisms of regulation and inhibition in mitotic kinases at University of Leeds on FindAPhD.com
PhD Project - Probing covalent mechanisms of regulation and inhibition in mitotic kinases at University of Leeds, listed on FindAPhD.com
www.findaphd.com
December 28, 2024 at 5:12 PM
I am happy to share that our recent work has been published in Angewandte Chemie.

We demonstrate how ‘direct-to-biology’ screening can accelerate optimisation campaigns, yielding potent covalent and non-covalent inhibitors from reactive fragment hits.

onlinelibrary.wiley.com/doi/full/10....
Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening
Direct-to-biology workflows promise to accelerate hit optimisation for drug discovery. Here, we describe a direct-to-biology method for the efficient synthesis and screening of cysteine-reactive frag...
onlinelibrary.wiley.com
December 11, 2024 at 5:50 PM